Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells

Shunji Chi, Chifumi Kitanaka, Kohji Noguchi, Toshihiro Mochizuki, Yohji Nagashima, Mikako Shirouzu, Hideaki Fujita, Midori Yoshida, Wenbin Chen, Akio Asai, Masaru Himeno, Shigeyuki Yokoyama, Yoshiyuki Kuchino

Research output: Contribution to journalArticle

179 Citations (Scopus)

Abstract

To prevent neoplasia, cells of multicellular organisms activate cellular disposal programs such as apoptosis in response to deregulated oncogene expression, making the suppression of such programs an essential step for potentially neoplastic cells to become established as clinically relevant tumors. Since the mutation of ras proto-oncogenes, the most frequently mutated protooncogenes in human tumors, is very rare in some tumor types such as glioblastomas and gastric cancers, we hypothesized that mutated ras genes might activate a cell death program that cannot be overcome by these tumor types. Here we show that the expression of oncogenically mutated ras gene induces cellular degeneration accompanied by cytoplasmic vacuoles in human glioma and gastric cancer cell lines. Cells dying as a result of oncogenic Ras expression had relatively well-preserved nuclei that were negative for TUNEL staining. An immunocytochemical analysis demonstrated that the cytoplasmic vacuoles are derived mainly from lysosomes. This oncogenic Ras-induced cell death occurred in the absence of caspase activation, and was not inhibited by the overexpression of anti-apoptotic Bcl-2 protein. These observations suggested that oncogenic Ras-induced cell death is most consistent with a type of programmed cell death designated 'type 2 physiological cell death' or 'autophagic degeneration', and that this cell death is regulated by a molecular mechanism distinct from that of apoptosis. Our findings suggest a possible role for this non-apoptotic cell death in the prevention of neoplasia, and the activation of the non-apoptotic cell death program may become a potential cancer therapy complementing apoptosis-based therapies. In addition, the approach used in this study may be a valuable way to find genetically-regulated cell suicide programs that cannot be overcome by particular tumor types.

Original languageEnglish
Pages (from-to)2281-2290
Number of pages10
JournalOncogene
Volume18
Issue number13
Publication statusPublished - 1999 Apr 1
Externally publishedYes

Fingerprint

Caspases
Suicide
Cell Death
ras Genes
Neoplasms
Autophagy
Apoptosis
Vacuoles
Stomach Neoplasms
Negative Staining
Proto-Oncogenes
In Situ Nick-End Labeling
Glioblastoma
Lysosomes
Oncogenes
Glioma
Cell Line
Mutation
Therapeutics

Keywords

  • Bcl-2
  • Caspase
  • Human glioma
  • Oncogenic Ras

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Chi, S., Kitanaka, C., Noguchi, K., Mochizuki, T., Nagashima, Y., Shirouzu, M., ... Kuchino, Y. (1999). Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene, 18(13), 2281-2290.

Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. / Chi, Shunji; Kitanaka, Chifumi; Noguchi, Kohji; Mochizuki, Toshihiro; Nagashima, Yohji; Shirouzu, Mikako; Fujita, Hideaki; Yoshida, Midori; Chen, Wenbin; Asai, Akio; Himeno, Masaru; Yokoyama, Shigeyuki; Kuchino, Yoshiyuki.

In: Oncogene, Vol. 18, No. 13, 01.04.1999, p. 2281-2290.

Research output: Contribution to journalArticle

Chi, S, Kitanaka, C, Noguchi, K, Mochizuki, T, Nagashima, Y, Shirouzu, M, Fujita, H, Yoshida, M, Chen, W, Asai, A, Himeno, M, Yokoyama, S & Kuchino, Y 1999, 'Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells', Oncogene, vol. 18, no. 13, pp. 2281-2290.
Chi S, Kitanaka C, Noguchi K, Mochizuki T, Nagashima Y, Shirouzu M et al. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene. 1999 Apr 1;18(13):2281-2290.
Chi, Shunji ; Kitanaka, Chifumi ; Noguchi, Kohji ; Mochizuki, Toshihiro ; Nagashima, Yohji ; Shirouzu, Mikako ; Fujita, Hideaki ; Yoshida, Midori ; Chen, Wenbin ; Asai, Akio ; Himeno, Masaru ; Yokoyama, Shigeyuki ; Kuchino, Yoshiyuki. / Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. In: Oncogene. 1999 ; Vol. 18, No. 13. pp. 2281-2290.
@article{9b9a2b17df764f84bbcb848f943e3dd1,
title = "Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells",
abstract = "To prevent neoplasia, cells of multicellular organisms activate cellular disposal programs such as apoptosis in response to deregulated oncogene expression, making the suppression of such programs an essential step for potentially neoplastic cells to become established as clinically relevant tumors. Since the mutation of ras proto-oncogenes, the most frequently mutated protooncogenes in human tumors, is very rare in some tumor types such as glioblastomas and gastric cancers, we hypothesized that mutated ras genes might activate a cell death program that cannot be overcome by these tumor types. Here we show that the expression of oncogenically mutated ras gene induces cellular degeneration accompanied by cytoplasmic vacuoles in human glioma and gastric cancer cell lines. Cells dying as a result of oncogenic Ras expression had relatively well-preserved nuclei that were negative for TUNEL staining. An immunocytochemical analysis demonstrated that the cytoplasmic vacuoles are derived mainly from lysosomes. This oncogenic Ras-induced cell death occurred in the absence of caspase activation, and was not inhibited by the overexpression of anti-apoptotic Bcl-2 protein. These observations suggested that oncogenic Ras-induced cell death is most consistent with a type of programmed cell death designated 'type 2 physiological cell death' or 'autophagic degeneration', and that this cell death is regulated by a molecular mechanism distinct from that of apoptosis. Our findings suggest a possible role for this non-apoptotic cell death in the prevention of neoplasia, and the activation of the non-apoptotic cell death program may become a potential cancer therapy complementing apoptosis-based therapies. In addition, the approach used in this study may be a valuable way to find genetically-regulated cell suicide programs that cannot be overcome by particular tumor types.",
keywords = "Bcl-2, Caspase, Human glioma, Oncogenic Ras",
author = "Shunji Chi and Chifumi Kitanaka and Kohji Noguchi and Toshihiro Mochizuki and Yohji Nagashima and Mikako Shirouzu and Hideaki Fujita and Midori Yoshida and Wenbin Chen and Akio Asai and Masaru Himeno and Shigeyuki Yokoyama and Yoshiyuki Kuchino",
year = "1999",
month = "4",
day = "1",
language = "English",
volume = "18",
pages = "2281--2290",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "13",

}

TY - JOUR

T1 - Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells

AU - Chi, Shunji

AU - Kitanaka, Chifumi

AU - Noguchi, Kohji

AU - Mochizuki, Toshihiro

AU - Nagashima, Yohji

AU - Shirouzu, Mikako

AU - Fujita, Hideaki

AU - Yoshida, Midori

AU - Chen, Wenbin

AU - Asai, Akio

AU - Himeno, Masaru

AU - Yokoyama, Shigeyuki

AU - Kuchino, Yoshiyuki

PY - 1999/4/1

Y1 - 1999/4/1

N2 - To prevent neoplasia, cells of multicellular organisms activate cellular disposal programs such as apoptosis in response to deregulated oncogene expression, making the suppression of such programs an essential step for potentially neoplastic cells to become established as clinically relevant tumors. Since the mutation of ras proto-oncogenes, the most frequently mutated protooncogenes in human tumors, is very rare in some tumor types such as glioblastomas and gastric cancers, we hypothesized that mutated ras genes might activate a cell death program that cannot be overcome by these tumor types. Here we show that the expression of oncogenically mutated ras gene induces cellular degeneration accompanied by cytoplasmic vacuoles in human glioma and gastric cancer cell lines. Cells dying as a result of oncogenic Ras expression had relatively well-preserved nuclei that were negative for TUNEL staining. An immunocytochemical analysis demonstrated that the cytoplasmic vacuoles are derived mainly from lysosomes. This oncogenic Ras-induced cell death occurred in the absence of caspase activation, and was not inhibited by the overexpression of anti-apoptotic Bcl-2 protein. These observations suggested that oncogenic Ras-induced cell death is most consistent with a type of programmed cell death designated 'type 2 physiological cell death' or 'autophagic degeneration', and that this cell death is regulated by a molecular mechanism distinct from that of apoptosis. Our findings suggest a possible role for this non-apoptotic cell death in the prevention of neoplasia, and the activation of the non-apoptotic cell death program may become a potential cancer therapy complementing apoptosis-based therapies. In addition, the approach used in this study may be a valuable way to find genetically-regulated cell suicide programs that cannot be overcome by particular tumor types.

AB - To prevent neoplasia, cells of multicellular organisms activate cellular disposal programs such as apoptosis in response to deregulated oncogene expression, making the suppression of such programs an essential step for potentially neoplastic cells to become established as clinically relevant tumors. Since the mutation of ras proto-oncogenes, the most frequently mutated protooncogenes in human tumors, is very rare in some tumor types such as glioblastomas and gastric cancers, we hypothesized that mutated ras genes might activate a cell death program that cannot be overcome by these tumor types. Here we show that the expression of oncogenically mutated ras gene induces cellular degeneration accompanied by cytoplasmic vacuoles in human glioma and gastric cancer cell lines. Cells dying as a result of oncogenic Ras expression had relatively well-preserved nuclei that were negative for TUNEL staining. An immunocytochemical analysis demonstrated that the cytoplasmic vacuoles are derived mainly from lysosomes. This oncogenic Ras-induced cell death occurred in the absence of caspase activation, and was not inhibited by the overexpression of anti-apoptotic Bcl-2 protein. These observations suggested that oncogenic Ras-induced cell death is most consistent with a type of programmed cell death designated 'type 2 physiological cell death' or 'autophagic degeneration', and that this cell death is regulated by a molecular mechanism distinct from that of apoptosis. Our findings suggest a possible role for this non-apoptotic cell death in the prevention of neoplasia, and the activation of the non-apoptotic cell death program may become a potential cancer therapy complementing apoptosis-based therapies. In addition, the approach used in this study may be a valuable way to find genetically-regulated cell suicide programs that cannot be overcome by particular tumor types.

KW - Bcl-2

KW - Caspase

KW - Human glioma

KW - Oncogenic Ras

UR - http://www.scopus.com/inward/record.url?scp=0033118229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033118229&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 2281

EP - 2290

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 13

ER -